Filing Details

Accession Number:
0001140361-14-008100
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-14 17:36:09
Reporting Period:
2014-02-12
Filing Date:
2014-02-14
Accepted Time:
2014-02-14 17:36:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
350907 Thoratec Corp THOR Electromedical & Electrotherapeutic Apparatus (3845) 942340464
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1307313 F Gerhard Burbach 6035 Stoneridge Drive
Pleasanton CA 94588
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-02-12 5,000 $23.62 161,307 No 4 M Direct
Common Stock Disposition 2014-02-12 5,000 $36.01 156,307 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2014-02-12 5,000 $0.00 5,000 $23.62
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
27,104 2007-01-17 2016-01-17 No 4 M Direct
Footnotes
  1. Options were granted pursuant to the Company's equity incentive plan with no payments received for the options.
  2. Options vest in four equal annual installments commencing one year after the grant date.
  3. Options exercised and shares of Common Stock sold pursuant to a Sales Plan established by the Reporting Person on September 9, 2013, which Sales Plan is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Securities Exchange Act of 1934, as amended.
  4. This transaction was executed in multiple trades in prices ranging from $36.00 to $36.02. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.